Since gastrin has been shown to stimulate growth of human gastric cancer (19), researchers have been studying means to block gastrin’s actions in gastric cancer using CCK-BR antagonists (23, 24) and their use in human trials reviewed (25–27). This evidence concerns the gene CCKBR and gastric cancer.